CASI Pharmaceuticals Inc. (CASI)
(Delayed Data from NSDQ)
$1.52 USD
-0.15 (-8.98%)
Updated Sep 23, 2025 04:00 PM ET
After-Market: $1.58 +0.06 (3.95%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
CASI Pharmaceuticals Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CASI 1.52 -0.15(-8.98%)
Will CASI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CASI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CASI
Veeva Systems (VEEV) Surpasses Q2 Earnings and Revenue Estimates
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
CASI: What are Zacks experts saying now?
Zacks Private Portfolio Services
VAXART, INC. (VXRT) Reports Q2 Loss, Beats Revenue Estimates
Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Lags Revenue Estimates
Other News for CASI
CASI forms Lower Bollinger Band Walk on September 22
CASI forms MACD Bearish Centerline Cross on September 19
Fell Below 50 Day Moving Average appears for CASI after 6.56% move
CASI forms Lower Bollinger Band Walk on September 17
Is CASI gathering momentum? Narrow Range Bar shows up after sliding 3.83%